Tuberculosis surveillance and monitoring in Europe 2016
The eighth report launched jointly by ECDC and the WHO Regional Office for Europe indicates that, despite notable progress in the past decade, tuberculosis (TB) is still a public health concern in many countries across Europe.
Molecular typing for surveillance of multidrug-resistant tuberculosis in the EU/EEA – January 2016
This report describes the geographical and temporal distribution of multidrug-resistant tuberculosis based on molecular typing data (24-locus MIRU–VNTR genotyping) as reported by EU/EEA countries.
Molecular typing for surveillance of multidrug-resistant tuberculosis in the EU/EEA
This report describes the geographical and temporal distribution of multidrug-resistant (MDR) tuberculosis (TB) using molecular typing data reported by European Union (EU)/European Economic Area (EEA) Member States for 2015 and the preceding years.
Tuberculosis surveillance and monitoring in Europe, 2017
This report, the ninth report launched jointly by ECDC and the WHO Regional Office for Europe, presents the latest data on the status of tuberculosis in Europe.
Tuberculosis surveillance and monitoring in Europe, 2018
The Annual TB Surveillance and Monitoring report presents the key figures and trends and provides an overview of the TB situation in the EU/EEA and the WHO European Region.
Drug-resistant tuberculosis in eastern Europe and central Asia: a time-series analysis of routine surveillance data
Dadu A, Hovhannesyan A, Ahmedov S, van der Werf MJ, Dara M.
Treatment and outcomes in children with multidrug-resistant tuberculosis: A systematic review and individual patient data meta-analysis
Harausz, E.P., Garcia-Prats, A.J., Law, S., Schaaf, H.S., Kredo, T., Seddon, J.A., Menzies, D., Turkova, A., Achar, J., Amanullah, F., Barry, P., Becerra, M., Chan, E.D., Chan, P.C., Ioana Chiotan, D., Crossa, A., Drobac, P.C., Fairlie, L., Falzon, D., Flood, J., Gegia, M., Hicks, R.M., Isaakidis, P., Kadri, S.M., Kampmann, B., Madhi, S.A., Marais, E., Mariandyshev, A., Méndez-Echevarría, A., Moore, B.K., Nargiza, P., Ozere, I., Padayatchi, N., ur-Rehman, S., Rybak, N., Santiago-Garcia, B., Shah, N.S., Sharma, S., Shim, T.S., Skrahina, A., Soriano-Arandes, A., van den Boom, M., van der Werf, M.J., van der Werf, T.S., Williams, B., Yablokova, E., Yim, J.-J., Furin, J., Hesseling, A.C.
- Drug-resistant tuberculosis
- HIV infection
- Multidrug resistance
- Multidrug-resistant tuberculosis
- Prevention and control
- South Africa
- South Korea
- United Kingdom
- United States
'treatment is of primary importance, and social assistance is secondary': A qualitative study on the organisation of tuberculosis (TB) care and patients' experience of starting and staying on TB treatment in Riga, Latvia
Kielmann, K., Vidal, N., Riekstina, V., Krutikov, M., Werf, M.J.V., Biraua, E., Duric, P., Moore, D.A.J.
Health system factors influencing management of multidrug-resistant tuberculosis in four European Union countries - learning from country experiences
De Vries, G., Tsolova, S., Anderson, L.F., Gebhard, A.C., Heldal, E., Hollo, V., Cejudo, L.S.C., Schmid, D., Schreuder, B., Varleva, T., Van der Werf, M.J.